Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:53:56 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



Q:VINC - VINCERX PHARMA INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VINC - Q2.80.718·0.84660.10.72-0.0279-3.7200.41088190.7467  0.7563  0.71519.3722  0.61May 16May 1415 min RT 2¢

Recent Trades - Last 10 of 819
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-14 16:15U:VINCNews ReleaseVincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
2024-04-26 00:27U:VINCNews ReleaseVincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
2024-04-25 16:01U:VINCNews ReleaseVincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
2024-04-08 16:30U:VINCNews ReleaseVincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
2024-04-01 08:00U:VINCNews ReleaseVincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
2024-03-29 15:21U:VINCNews ReleaseVincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
2024-03-05 16:31U:VINCNews ReleaseVincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
2024-01-07 15:00U:VINCNews ReleaseVincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
2023-12-10 12:00U:VINCNews ReleaseVincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023
2023-11-14 07:00U:VINCNews ReleaseVincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2023-11-02 09:10U:VINCNews ReleaseVincerx Pharma To Present Three Posters at ASH 2023 in December
2023-10-13 09:12U:VINCNews ReleaseNew to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network
2023-10-06 09:30U:VINCNews ReleaseNew to The Street Announces TV Corporate Appearances, broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ET
2023-09-19 07:00U:VINCNews ReleaseVincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023
2023-09-14 07:00U:VINCNews ReleaseVincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943
2023-08-22 07:30U:VINCNews ReleaseVincerx Pharma Announces FDA Clearance of IND for VIP943
2023-08-07 09:25U:VINCNews ReleaseVincerx Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update